TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 5 | -2 | 4 | 38 | 22 | 62 | 21 |
| P | %wins | 100 | 0 | 50 | 100 | 50 | 50 | 58 | |||
| S | %ret | 1 | 1 | 1 | -1 | 0 | 32 | 5 | 57 | -33 | 12 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/27/14 14:20 | 5/22/14 | AERI | Aerie Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Acp Iv, L.P. | CA | T | S | -4,800 | 16.00 | 1 | -300 | -8 | 3,616 | D | 35 | -20 | -6 | 3 | -4 | 2 | -1 | 0 | 32 | 5 | 57 | -33 | |||
11/1/13 19:38 | 10/30/13 | AERI | Aerie Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Acp Iv, L.P. | CA | T | P.d | 1,100 | 10.00 | 7 | 110 | 3 | 3,916 | D | 0 | 3 | -1 | 9 | 62 | 47 | 140 | ||||||||
2/18/11 17:49 | 2/16/11 | ACRX | Acelrx Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Acp Iv, L.P. | CA | T | P.d | 3,400 | 5.00 | 2 | 680 | 32 | 2,795 | D | -12 | 6 | -2 | -2 | 14 | -3 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |